IL6 and oral lichen planus: So, comparison of various therapeutic modalities for OLP regarding their effects on serum IL-6 levels reveals that there is a marked possibility for these markers to help decide the best possible therapy for a case, which after this study is proposed to be MTX supplemented with Pimecrolimus and a possible role of MMF supplemented with topical therapy in cases recalcitrant to MTX.